Wilmington, DE, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:
- Canaccord Genuity 43rd Annual Growth Conference: On Wednesday, August 9th, Ben Berry, Chief Financial Officer, will be meeting with investors at the conference which is scheduled to take place in Boston, MA.
- Baird 2023 Global Healthcare Conference: On Tuesday, September 12th, Ben Berry, Chief Financial Officer, and Brady Shirley, Chief Operating Officer, will be meeting with investors at the conference, which is scheduled to take place in New York, NY.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Contact:
Derek Leckow
Vice President, Investor Relations
Enovis Corporation
+1-302-421-1971
investorrelations@enovis.com
***
Source: Enovis Corporation
